Skip to main content

Table 4 The characteristics of non-alcoholic fatty liver disease participants compared to those with no liver involvement in the non-excessive alcohol consumption group

From: The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database

 

NAFLD

No NAFLD

p value

N = 506

N = 713

Age (years)—mean (95% CI)

30.00 (29.28–30.72)

27.53 (26.83–28.24)

 < 0.001

Male—% (95% CI)

58.09 (50.92–64.92)

46.55 (40.47–52.74)

0.016

BMI (kg/m2)—mean (95% CI)

34.116 (32.80–35.43)

25.58 (24.85–26.3)

 < 0.001

Race/ethnicity—% (95% CI)

Non-Hispanic White

50.39 (41.47–59.28)

58.82 (51.21–66.04)

0.001

Non-Hispanic Black

9.56 (5.91–15.11)

14.41 (10.7–19.13)

 

Hispanic

29.08 (21.19–38.49)

17.77 (13.15–23.57)

 

Non-Hispanic Asian

6.14 (4.15–8.98)

4.39 (2.54–7.49)

 

Non-Hispanic other

4.83 (3.23–7.16)

4.6 (2.8–7.48)

 

Smoking status—% (95% CI)

Never

59.88 (51.56–67.67)

67.02 (60.11–73.28)

0.054

Former

22.4 (16.56–29.56)

14.81 (10.25–20.93)

 

Current

17.72 (12.97–23.74)

18.16 (14.29–22.8)

 

Lab values—mean (95% CI)

Total bilirubin (mg/dL)

0.46 (0.41–0.5)

0.49 (0.45–0.54)

0.172

AST (IU/L)

23.9 (22.4–25.4)

20.62 (19.02–22.23)

0.018

ALT (IU/L)

31.15 (27.29–35.01)

19.26 (17.78–20.73)

 < 0.001

Albumin (g/dL)

4.14 (4.06–4.22)

4.23 (4.17–4.28)

0.020

MCV (fL)

86.34 (85.53–87.15)

88.43 (87.78–89.08)

 < 0.001

Platelet count (103 cells/uL)

265.58 (254.51–276.64)

245.45 (239.04–251.86)

 < 0.001

HbA1C (%)

5.46 (5.37–5.55)

5.21 (5.18–5.24)

 < 0.001